AAAAAA
Results:
1-20
|
Results: 20
Authors:
STANISLAUS F
LAICHER A
VONNIECIECKI A
Citation: F. Stanislaus et al., SPECIAL SECTION - BIOTECHNOLOGY IN DRUG RESEARCH - PREFACE, Arzneimittel-Forschung, 48(5A), 1998, pp. 534-534
Authors:
LAICHER A
FUCHS WS
Citation: A. Laicher et Ws. Fuchs, PELLET TECHNOLOGY SUSTAINED-RELEASE PELLETS IN HARD GELATIN CAPSULES - A SUITABLE DOSAGE FORM FOR THEOPHYLLINE, Arzneimittel-Forschung, 48(5A), 1998, pp. 540-547
Authors:
GRUNENBERG P
LORCK C
JUNGER H
LAICHER A
Citation: P. Grunenberg et al., EXPERIENCE IN SCALING-UP THE FILM COATING PROCESS FOR THEOPHYLLINE SUSTAINED-RELEASE PELLETS, Arzneimittel-Forschung, 48(5A), 1998, pp. 547-551
Authors:
FUCHS WS
JAKOBS R
GRUNENBERG P
WEISS G
PROFITLICH T
VONNIECIECKI A
KLEMM FH
LAICHER A
STANISLAUS F
Citation: Ws. Fuchs et al., INFLUENCE OF DIFFERENT VARIABLES ON THE IN-VITRO DISSOLUTION OF A SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORM, Arzneimittel-Forschung, 48(5A), 1998, pp. 552-556
Authors:
VONNIECIECKI A
FUCHS WS
PABST G
MULLER M
DILGER C
GAY S
LAICHER A
STANISLAUS F
Citation: A. Vonnieciecki et al., IN-VIVO VERIFICATION OF THE IN-VITRO RELEASE SPECIFICATION OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION, Arzneimittel-Forschung, 48(5A), 1998, pp. 580-583
Authors:
FUCHS WS
VONNIECIECKI A
PABST G
MULLER M
DILGER C
GAY S
LAICHER A
STANISLAUS F
Citation: Ws. Fuchs et al., PHARMACOKINETICS OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION FOLLOWING ONCE-A-DAY AND TWICE-A-DAY MULTIPLE DOSING, Arzneimittel-Forschung, 48(5A), 1998, pp. 589-592
Authors:
WITSCHITAL K
FUCHS WS
HEESE U
VONNIECIECKI A
LAICHER A
Citation: K. Witschital et al., PHARMACOKINETICS OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION IN YOUNG ASTHMATICS, Arzneimittel-Forschung, 48(5A), 1998, pp. 593-596
Authors:
FUCHS WS
VONNIECIECKI A
MOLZ KH
POPESCU G
WEIL A
BARKWORTH MF
GAY S
LAICHER A
STANISLAUS F
Citation: Ws. Fuchs et al., EFFECT OF CHOLAGOGIA ON THE PHARMACOKINETIC PROFILE OF A SUSTAINED-RELEASE THEOPHYLLINE FORMULATION, Arzneimittel-Forschung, 48(5A), 1998, pp. 597-604
Authors:
FUCHS WS
WEISS G
VONNIECIECKI A
LAICHER A
GAY S
PABST G
MULLER R
Citation: Ws. Fuchs et al., PHARMACOKINETIC CHARACTERISTICS OF A NEW LIQUID SUSTAINED-RELEASE FORMULATION OF THEOPHYLLINE - MICROCAPS AS SACHET, Arzneimittel-Forschung, 48(5A), 1998, pp. 612-617
Authors:
LAICHER A
PROFITLICH T
SCHWITZER K
AHLERT D
Citation: A. Laicher et al., A MODIFIED SIGNAL ANALYSIS SYSTEM FOR END-POINT CONTROL DURING GRANULATION, European journal of pharmaceutical sciences, 5(1), 1997, pp. 7-14
Authors:
LAICHER A
JUNGER H
KLEMM FH
Citation: A. Laicher et al., STABILITY BEHAVIOR OF MOLSIDOMINE-CONTAINING PELLET FORMULATIONS, Journal of Pharmacy and Pharmacology, 49(2), 1997, pp. 131-134
Authors:
FUCHS WS
WEISS G
VONNIECIECKI A
LAICHER A
GAY S
PABST G
MULLER M
Citation: Ws. Fuchs et al., PHARMACOKINETIC CHARACTERISTICS OF A NEW LIQUID SUSTAINED-RELEASE FORMULATION OF THEOPHYLLINE DESIGNED FOR THE ELDERLY AND CHILDREN - MICROCAPS AS SACHET, International journal of clinical pharmacology and therapeutics, 34(12), 1996, pp. 558-563
Authors:
FUCHS WS
VONNIECIECKI A
MOLZ KH
POPESCU G
WEIL A
BARKWORTH MF
GAY S
LAICHER A
STANISLAUS F
Citation: Ws. Fuchs et al., EFFECT OF GALLBLADDER CONTRACTION INDUCED CHOLAGOGIA ON THE PHARMACOKINETIC PROFILE OF A SUSTAINED-RELEASE THEOPHYLLINE FORMULATION, Arzneimittel-Forschung, 46(12), 1996, pp. 1120-1126
Authors:
WEISS G
KNOCH A
LAICHER A
STANISLAUS F
DANIELS R
Citation: G. Weiss et al., SIMPLE COACERVATION OF HYDROXYPROPYL METHYLCELLULOSE PHTHALATE (HPMCP) .1. TEMPERATURE AND PH DEPENDENCY OF COACERVATE FORMATION, International journal of pharmaceutics, 124(1), 1995, pp. 87-96
Authors:
WEISS G
KNOCH A
LAICHER A
STANISLAUS F
DANIELS R
Citation: G. Weiss et al., SIMPLE COACERVATION OF HYDROXYPROPYL METHYLCELLULOSE PHTHALATE (HPMCP) .2. MICROENCAPSULATION OF IBUPROFEN, International journal of pharmaceutics, 124(1), 1995, pp. 97-105
Authors:
LAICHER A
PROFITLICH T
Citation: A. Laicher et T. Profitlich, INFLUENCE OF TABLET FORMULATION AND SIZE ON THE IN-VITRO SUSTAINED-RELEASE BEHAVIOR OF METOPROLOL TARTRATE FROM HYDROPHILIC MATRICES, Drug development and industrial pharmacy, 21(17), 1995, pp. 1929-1939
Authors:
WALTER K
WEISS G
LAICHER A
STANISLAUS F
Citation: K. Walter et al., PHARMACOKINETICS OF IBUPROFEN FOLLOWING A SINGLE ADMINISTRATION OF A SUSPENSION CONTAINING ENTERIC-COATED MICROCAPSULES, Arzneimittel-Forschung, 45-2(8), 1995, pp. 886-890
Authors:
GRUNENBERG P
LAICHER A
Citation: P. Grunenberg et A. Laicher, VALIDATION OF A METHOD FOR PARTICLE-SIZE DETERMINATION BY LASER-LIGHTSCATTERING ANALYSIS, Die Pharmazie, 49(8), 1994, pp. 585-589
Authors:
WEISS G
KNOCH A
LAICHER A
STANISLAUS F
DANIELS R
Citation: G. Weiss et al., MICROENCAPSULATION OF IBUPROFEN BY A COACERVATION PROCESS USING EUDRAGIT L100-55 AS AN ENTERIC POLYMER, Drug development and industrial pharmacy, 19(20), 1993, pp. 2751-2764
Authors:
LAICHER A
LORCK CA
GRUNENBERG PC
KLEMM H
STANISLAUS F
Citation: A. Laicher et al., AQUEOUS COATING OF PELLETS TO SUSTAINED-RELEASE DOSAGE FORMS IN A FLUID-BED COATER - INFLUENCE OF PRODUCT TEMPERATURE AND POLYMER CONCENTRATION ON IN-VITRO RELEASE, Pharmazeutische Industrie, 55(12), 1993, pp. 1113-1116
Risultati:
1-20
|